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MicroRNAs (miRNAs) are an extensive class of noncoding genes that regulate gene expression through
posttranscriptional repression. Given the potential for large viral genomes to encode these transcripts, we
examined the human cytomegalovirus AD169 genome for miRNAs using a bioinformatics approach. We
identified 406 potential stem-loops, of which 110 were conserved between chimpanzee cytomegalovirus and
several strains of human cytomegalovirus. Of these conserved stem-loops, 13 exhibited a significant score using
the MiRscan algorithm. Examination of total RNA from human cytomegalovirus-infected cells demonstrated
that 5 of the 13 predicted miRNAs were expressed during infection. These studies demonstrate that human
cytomegalovirus encodes multiple conserved miRNAs and suggest that human cytomegalovirus may utilize an
miRNA strategy to regulate cellular and viral gene function.
MicroRNAs (miRNAs) are a large class of noncoding RNAs
involved in posttranscriptional regulation through RNA inter-
ference. A number of recent studies have identified virally
encoded miRNAs using either biochemical cloning strategies,
bioinformatics, or a combination of the two approaches (1, 2,
4, 7–9). In this study an alternative bioinformatics approach
based on comparative conservation between predicted stem-
loop sequences of human cytomegalovirus (HCMV) and chim-
panzee cytomegalovirus (CCMV) was used to predict candi-
date miRNAs. Expression of predicted miRNAs during
HCMV infection was then assessed by Northern blot analysis.
Our bioinformatics approach utilized a computer algorithm
called Stem-loop Finder (SLF; Combimatrix) to predict poten-
tial RNA transcripts from the HCMV genome that could form
stem-loop secondary structures. The algorithm uses free en-
ergy calculations to determine the theoretical stability of the
base pairing within the stem region, including pairing between
G · U bases, while maintaining a maximum and minimum
length between the complementary base pairing to determine
loop size. A scoring matrix then weights beneficial or detri-
mental folding structures and attributes a cumulative score to
each potential stem-loop sequence. Analysis of the HCMV
genome using SLF identified 406 potential stem-loop se-
quences. Previously identified miRNAs are often extensively
conserved between many different species (6). Consequently,
we hypothesized that functionally important miRNAs ex-
pressed by HCMV would be conserved between HCMV and
closely related viruses, such as CCMV. The sequence of each
of the 406 candidate SLF-derived HCMV stem-loop tran-
scripts was compared with the CCMV genome for potential
homology. A minimum score of 60% homology with CCMV
was used to select stem-loop sequences for further analysis.
Our preliminary studies determined that this level of homology
was sufficiently stringent to identify significant sequence con-
servation without exclusion of any potential miRNAs. Of the
406 sequences analyzed, 110 potential stem-loop sequences
scored higher than 60% homology.
The 110 HCMV stem-loop sequences selected using the
criteria (detailed above) and the corresponding homologous
CCMV sequences were then analyzed using a bioinformatics
program (MiRscan) (5) to predict which of the conserved
stem-loop sequences had a high probability of encoding gen-
uine miRNA transcripts. The MiRscan program compares two
sequences and provides a score based on a number of aspects,
such as the ability to form a stem-loop, symmetry of bulge
loops, and conservation of the predicted miRNA sequence
within the stem-loop. Specific sequence bias within the 5 re-
gion of the miRNA, such as a propensity for the first base of
the miRNA to be a uracil, is also a criterion for the program.
The program then predicts a candidate miRNA that would be
generated from the pre-miRNA stem-loop structure. In a sim-
ilar previous study, stem-loop sequences that scored higher
than 10 using the MiRscan algorithm were experimentally
tested (5). The 110 HCMV stem-loop sequences selected using
the criteria mentioned above and the corresponding homolo-
gous CCMV sequences were analyzed using the MiRscan pro-
gram. Of the 110 sequences analyzed, 13 scored higher than 10
using the MiRscan algorithm. The 13 candidate miRNAs are
shown in Table 1, with the predicted secondary structures
shown in Fig. 1. To determine whether the predicted miRNAs
were expressed by HCMV, Northern blot analysis of total
RNA from infected cells was performed using end-labeled
oligonucleotide probes. In each case probes complementary to
both the full 5 stem sequence and 3 stem sequence, as well as
probes for the predicted miRNA sequence, were used. Follow-
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ing infection of primary fibroblast cells with HCMV AD169,
total RNA was harvested at 2, 8, 24, 48, and 72 h postinfection
(p.i.). Total RNA from uninfected fibroblast cells was included
as a negative control. Four of the predicted miRNAs, UL36-1,
US4-1, US5-1, and US5-2, were detected in infected RNA
samples, with an additional miRNA, UL70-1, detected using a
probe to the complementary strand of the stem-loop (Fig. 2).
UL36-1 expression was first detected 24 h p.i. and continued to
accumulate over time, with peak levels being detected 72 h p.i.
A band of approximately 80 bases in length was also detected
as early as 8 h p.i. and was present throughout the remainder
of the time course. The pre-miRNA stem-loop transcript can
often be detected in addition to the miRNA species as a band
60 to 80 bases in length. Therefore, the 80-base species
detected in the UL36-1 blot correlates with the pre-miRNA of
UL36-1. The probe for US4-1 detected a band of approxi-
mately 24 to 25 bases in length, slightly larger than the other
viral miRNAs. Previous cloning studies have determined that
the 3 end of miRNAs often varies by one or two bases (5),
which was consistent with our detection of a smear of smaller
RNA species below the major US4-1 band that resolved into at
least two individual bands upon further analysis (Fig. 3). Ex-
pression of US5-1 and US5-2 was also first detected 24 h p.i.
and, like UL36-1, continued to accumulate throughout the
time course. In previous studies, the complementary strand of
the miRNA duplex formed from the stem-loop precursor was
TABLE 1. Predicted miRNA sequences of HCMVa
Stem-loop Conservationscore vs CCMV
MiRscan
score
Nucleotide coordinates
of stem-loop Relative genome position Predicted miR
UL22-1 64 10.27 C 27639 to 27716 Between UL22-UL23 UCACGGGAAGGCUAGUUAGAC
UL31-1 80 11.80 C 39176 to 39258 A/S UL31 CGGCAUGUUGCGCGCCGUGAU
UL36-1 87 12.85 C 49502 to 49563 UL36 intron AGACACCUGGAAAGAGGACGU
UL53-1 90 12.24 C 77054 to 77134 A/S UL53 UGCGCGAGACCUGCUCGUUGC
UL54-1 82 12.57 C 79184 to 79276 UL54 UGCGCGUCUCGGUGCUCUCGG
UL70-1 84 10.28 104018 to 104083 A/S UL70 UGCGUCUCGGCCUCGUCCAGA
UL102-1 87 13.39 148054 to 148113 UL102 UGGCCAUGUCGUUUCGCGUCG
UL102-2 82 12.95 C 148703 to 148767 A/S UL102 UGGCGUCGUCGCUCGGCGGGU
UL111a-1 93 14.64 161368 to 161436 Between UL111a-UL112/113 UGACGUUGUUUGUGGGUGUUG
US4-1 73 12.86 196080 to 196163 Partial US4 CGACAUGGACGUGCAGGGGGA
US5-1 62 14.77 196991 to 197056 Between US6-US7 UGACAAGCCUGACGAGAGCGU
US5-2 83 10.49 197120 to 197184 Between US6-US7 UGAUAGGUGUGACGAUGUCUU
US29-1 89 15.43 221396 to 221479 US29 UUGGAUGUGCUCGGACCGUGA
a For each of the 13 identified candidate miRNA stem-loop sequences, the nucleotide coordinates and genome positions relative to the annotated ORFs of HCMV
(AD169) are shown. The percentage conservation compared to CCMV and the overall MiRscan score are also indicated along with the predicted miRNA sequence.
C, complementary strand; A/S, antisense to ORF shown.
FIG. 1. Predicted stem-loop secondary structures of HCMV-encoded candidate miRNAs. Sequences in red indicate the miRNA sequences
predicted by the MiRscan algorithm. For UL70-1, the detected miRNA is indicated in blue. Secondary structures were determined using Mfold
(11).
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not detected and was most likely rapidly degraded by cellular
enzymes. Interestingly, in the case of UL70-1, the sequence on
the complementary strand of the stem-loop corresponding to
the predicted miRNA (Fig. 1) was detected rather than the
predicted miRNA. This sequence was also first detected at 24 h
FIG. 2. Northern blot analysis of HCMV-expressed miRNAs. Hu-
man fibroblast cells were infected at a multiplicity of 5 PFU per cell.
Total RNA was harvested and subjected to Northern blot analysis
using probes specific for predicted viral miRNA sequences. (a) Ex-
pression of UL36-1 miRNA as well as the 80-base pre-miRNA spe-
cies. (b to e) Expression of miRNAs UL70-1, US4-1, US5-1, and
US5-2. Ethidium bromide staining of the tRNA band is shown as
loading control for each blot. Lane U, uninfected; other lanes are from
2, 8, 24, 48, and 72 h p.i. Positions of radioactive size markers are
indicated on the right of the blot.
FIG. 3. Expression kinetics of HCMV miRNAs. Human fibroblast
cells were treated with either cycloheximide, foscarnet, or with no drug
and infected at a multiplicity of 5 PFU per cell. At 36 h, total RNA was
harvested and subjected to Northern blot analysis. Total RNA from
infected cells was harvested as a negative control. Lanes: U, unin-
fected; I, infected, no drug; CHX, cycloheximide treated; FOS, foscar-
net treated. (a) Expression of UL36-1 miRNA and potential pre-
miRNA sequence. (b to e) Expression of UL70-1, US4-1, US5-1, and
US5-2. Positions of radioactive size markers are indicated on the right
of the blots. tRNA band loading control was visualized by ethidium
bromide staining of the polyacrylamide gel.
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p.i. but, unlike the other viral miRNAs, peak levels were de-
tected at 48 h p.i. and then dropped to lower levels at 72 h. In
each case, signal was not detected using probes to the opposite
arms of the stem-loops from which the miRNAs were detected,
indicating that the miRNA* species could not be detected by
Northern blotting and that the specific bands detected are not
due to degraded mRNA transcripts.
Expression of HCMV transcripts can be grouped into three
kinetic classes, immediate early, early, or late, based on their
requirement for expression of viral protein and viral DNA
replication (3). To determine the specific kinetic class of each
of the viral miRNAs, viral infections were performed in the
presence of either cycloheximide, which blocks protein trans-
lation, suggesting early gene expression, or foscarnet, which
blocks DNA replication, indicating late gene expression. Total
RNA samples were harvested 36 h p.i. followed by Northern
blot analysis. Figure 3 demonstrates that cycloheximide but not
foscarnet blocked the expression of UL36-1, indicating that
UL36-1 is expressed with early kinetics. This observation was
surprising, as the UL36 transcript that contains the intron
encoding the UL36-1 miRNA exhibits immediate early kinetics
(10). Furthermore, the 80-base species detected in the initial
Northern blot assay time course was detected at elevated levels
in the cycloheximide sample. One potential explanation for the
block in the production of mature miRNAs would be that the
extended cycloheximide treatment depleted proteins, such as
dicer, required for the processing of mature miRNAs. How-
ever, this expression pattern was unique to UL36-1; corre-
sponding species were not detected for UL70-1, US4-1, US5-1,
or US5-2 following cycloheximide treatment. Investigation of
earlier time points also demonstrated a similar expression pat-
tern for UL36-1 with as little as 14 h of cycloheximide treat-
ment, and levels of the cellular miRNA, miR-22, remained
unaffected after 36 h of cycloheximide treatment, suggesting
that the cells were still able to produce mature miRNAs (data
not shown). Two possible alternative explanations are that the
UL36-1 pre-miRNA is transcribed independently rather than
being processed from the UL36 intron, or that an early viral
gene product is required for the processing of UL36-1 from the
pre-miRNA transcript. Expression of US4-1, US5-1, and
US5-2 were blocked by cycloheximide treatment but not fos-
carnet treatment, indicating that these transcripts were also
expressed with early kinetics. In contrast, UL70-1 was ex-
pressed in the presence of cycloheximide, indicating that this
miRNA does not require de novo viral protein expression and
is therefore expressed with immediate-early kinetics. The
probe for UL70-1 also consistently cross-hybridized to a spe-
cies in the uninfected control sample. This cross hybridization
is unique to the UL70-1 sequence and does not occur with any
of the other viral probes. This observation may suggest that
UL70-1 has some homology to a cellular miRNA or that the
probe is nonspecifically binding to a cellular transcript.
A recent study by Pfeffer et al. (7) used a cloning technique
to identify miRNAs encoded by HCMV during acute infection
of fibroblast cells. A total of nine miRNAs were identified by
cloning, including three miRNAs from the same stem-loops
FIG. 4. Northern blot analysis of HCMV-expressed miRNAs. Human fibroblast cells were infected at a multiplicity of 5 PFU per cell. Total
RNA was harvested and subjected to Northern blot analysis using probes specific for predicted viral miRNA sequences. (a to d) Expression of
miRNAs UL22A-1, UL112-1, US25-1, and US25-2. Ethidium bromide staining of the tRNA band is shown as a loading control for each blot. Lane
U, uninfected; other lanes are from 2, 8, 24, 48, and 72 h p.i. (e to h) Expression of miRNAs in the presence of cycloheximide, foscarnet, or no
drug. Uninfected controls are shown. Lanes: U, uninfected; I, infected, no drug; CHX, cycloheximide treated; FOS, foscarnet treated.
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identified in this study (UL36-1, US5-1, and US5-2). To extend
the initial identification of these additional miRNAs, Northern
blot analysis was used to determine the expression kinetics
during HCMV acute infection. Figure 4 indicates that the
virally encoded miRNAs all follow a similar expression pattern,
with levels continuing to increase over time. The kinetic studies
also indicate that all the miRNAs with the exception of UL70-1
are expressed with early kinetics. We were unable to detect
US33-1 by Northern blot analysis.
The computer algorithm recently described by Pfeffer et al.
(7) identified sequences with the potential to form stem-loop
structures similar to previously identified pre-miRNAs. The
sequences were scored and then ranked, and a cutoff score was
determined, which reduced false positives. This approach pre-
dicted 11 pre-miRNAs, of which 5 were validated by cloning.
The approach used in this study not only utilized the charac-
teristic structural features of pre-miRNAs, but also made use
of comparative sequence conservation between HCMV and
CCMV. This approach was equally effective, with the identifi-
cation of five validated miRNAs, including two miRNAs,
UL70-1 and US4-1, not identified in the Pfeffer et al. study. Of
the remaining miRNAs identified by Pfeffer et al. using clon-
ing, all but one of the sequences was conserved in CCMV and
scored above or close to 10 using the MiRscan algorithm.
Therefore, by refining the SLF algorithm, the success rate of
the approach used in this study could be significantly increased
in future studies. One possible concern with both bioinformat-
ics approaches is the inability to precisely predict the position
of the mature miRNA within the stem-loop structure. Differ-
ences in the 5 and 3 ends of the sequences identified by
cloning compared to the predicted sequences of the miRNAs
identified by the MiRscan algorithm suggest that further re-
finement of the bioinformatics method is required to allow
accurate prediction of the exact sequence of the mature
miRNA. In conclusion, the data presented show that the ap-
proach used is a viable method for the prediction of miRNAs
expressed by viral genomes and will be useful in further inves-
tigations of viral miRNA identification.
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